Cormorant Asset Management LLC 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:05 pm Sale | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Cormorant Asset Management LLC | 1,679,442 2.020% | -4,731,913 (-73.81%) | Filing |
| 2021-02-16 3:33 pm Sale | 2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Cormorant Asset Management LLC | 6,411,355 7.760% | -475,000 (-6.90%) | Filing |
| 2020-11-13 4:01 pm Purchase | 2020-11-03 | 13G | Atea Pharmaceuticals, Inc. AVIR | Cormorant Asset Management LLC | 6,886,355 8.340% | 6,886,355 (New Position) | Filing |